Literature DB >> 18045244

Systematic review: nutritional therapy in paediatric Crohn's disease.

A S Day1, K E Whitten, M Sidler, D A Lemberg.   

Abstract

BACKGROUND: At least 25% of individuals diagnosed with Crohn's disease (CD) have onset of disease in childhood. Almost all children with CD have nutritional impairments, such as weight loss or stunting, at diagnosis or subsequently. Nutritional therapy (exclusive enteral nutrition) is established as a valid and effective treatment in paediatric CD. The advantages of this approach are induction of remission and control of inflammatory changes, mucosal healing, positive benefits to growth and overall nutritional status, and avoidance of other medical therapies. AIM: To provide a comprehensive up-to-date review of the roles of nutritional therapy in CD and of the data supporting this therapy.
METHODS: A search of PubMed was performed with search terms 'enteral nutrition', 'nutritional therapy', 'Crohn disease' and 'children'. Relevant articles were selected from this search. In addition, the reference lists of available articles were reviewed for further relevant articles.
RESULTS: Nutritional therapy offers numerous benefits in the management of CD. Recent work has begun to elucidate the likely mechanisms of this therapy. These include direct mucosal anti-inflammatory effects and alteration of intestinal microflora.
CONCLUSION: Further studies are required to define longer-term effects of nutritional therapy in patients with CD.

Entities:  

Mesh:

Year:  2007        PMID: 18045244     DOI: 10.1111/j.1365-2036.2007.03578.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  42 in total

1.  Longer-term outcomes of nutritional management of Crohn's disease in children.

Authors:  B Lambert; D A Lemberg; S T Leach; A S Day
Journal:  Dig Dis Sci       Date:  2012-06-02       Impact factor: 3.199

2.  Differential effects of nutritional and non-nutritional therapies on intestinal barrier function in an in vitro model.

Authors:  Lily Nahidi; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  J Gastroenterol       Date:  2011-09-28       Impact factor: 7.527

Review 3.  An update of the role of nutritional therapy in the management of Crohn's disease.

Authors:  Moftah H Alhagamhmad; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  J Gastroenterol       Date:  2012-06-15       Impact factor: 7.527

4.  Outcomes of exclusive enteral nutrition in paediatric Crohn's disease.

Authors:  L Lafferty; M Tuohy; A Carey; S Sugrue; M Hurley; S Hussey
Journal:  Eur J Clin Nutr       Date:  2016-11-23       Impact factor: 4.016

5.  The major pathway by which polymeric formula reduces inflammation in intestinal epithelial cells: a microarray-based analysis.

Authors:  Lily Nahidi; Susan M Corley; Marc R Wilkins; Jerry Wei; Moftah Alhagamhmad; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  Genes Nutr       Date:  2015-07-17       Impact factor: 5.523

Review 6.  Use of exclusive enteral nutrition in adults with Crohn's disease: a review.

Authors:  Catherine L Wall; Andrew S Day; Richard B Gearry
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

7.  Effect of exclusive enteral nutrition on bone turnover in children with Crohn's disease.

Authors:  Kylie E Whitten; Steven T Leach; Timothy D Bohane; Helen J Woodhead; Andrew S Day
Journal:  J Gastroenterol       Date:  2009-12-03       Impact factor: 7.527

8.  A Strong Impact of Genetic Background on Gut Microflora in Mice.

Authors:  R Steven Esworthy; David D Smith; Fong-Fong Chu
Journal:  Int J Inflam       Date:  2010-06-01

9.  Time to Relapse in Children with Crohn's Disease Treated with Azathioprine and Nutritional Therapy or Corticosteroids.

Authors:  Ondrej Hradsky; Ivana Copova; Kristyna Zarubova; Jiri Nevoral; Jiri Bronsky
Journal:  Dig Dis Sci       Date:  2016-03-12       Impact factor: 3.199

Review 10.  Calcium-sensing receptor: A new target for therapy of diarrhea.

Authors:  Sam Xianjun Cheng
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.